Pulse and active pulse spectraphotometry

• US 8,606,342 B2
• Filed: 10/31/2005
• Issued: 12/10/2013
• Est. Priority Date: 02/22/2002
• Status: Active Grant

• Current Assignee: Masimo Corporation
• Original Assignee: Cercacor Laboratories
• Inventors: Diab, Mohamed K.
• Primary Examiner(s): Winakur, Eric
• Assistant Examiner(s): BERHANU, ETSUB D
• Application Number:
  US11/263,404
• Publication Number:
  US 20060052680A1
• Time in Patent Office: 2,962 Days
• Field of Search: 600/310, 600/316, 600/322
• US Class Current: 600/316
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/14552 Details of sensors specially adapted therefor
• CPC Class Codes: A61B 5/6826 Finger
• CPC Class Codes: A61B 5/6838 Clamps or clips

Abstract

A pulse and active pulse spectraphotometry system comprises a light source adapted to illuminate a tissue site with optical radiation having a plurality of wavelengths selected from at least one of a primary band of about 1620 nm to about 1730 nm and a secondary band of about 1000 nm to about 1380 nm.

Claims

1. A noninvasive optical sensor capable of outputting a signal usable by a patient monitor to determine one or more physiological parameters of a wearer of the optical sensor, the optical sensor comprising:

a light source configured to irradiate tissue at a single tissue location, the light source emitting optical radiation at a number of discrete wavelengths, the number of discrete wavelengths consisting of one wavelength from a first wavelength band in a range of about 1620 nm to about 1655 nm when the light source emits said optical radiation at wavelengths in the first wavelength band, and consisting of one wavelength from a second wavelength band in a range of about 1000 nm to about 1102 nm when the light source emits said optical radiation at wavelengths in the second wavelength band, and

a detector capable of detecting the optical radiation after attenuation by body tissue and of outputting a signal indicative of the attenuation by the body tissue, the signal being usable by a patient monitor to determine one or more measurement values for blood glucose of the body tissue.

2. The noninvasive optical sensor according to claim 1 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1650 nm±

5 nm when the light source emits said optical radiation at wavelengths in the first wavelength band.

3. The noninvasive optical sensor according to claim 1 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1032 nm±

5 nm when the light source emits said optical radiation at wavelengths in the second wavelength band.

4. The noninvasive optical sensor according to claim 1 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1097 nm±

5 nm when the light source emits said optical radiation at wavelengths in the second wavelength band.

5. The noninvasive optical sensor according to claim 1 wherein the number of discrete wavelengths consists of one wavelength from a third wavelength band in a range of about 2000 nm to about 2500 nm when the light source emits said optical radiation at wavelengths in the third wavelength band.

6. A method of operating a noninvasive physiological sensor to acquire a signal indicative of one or more physiological parameters of body tissue, the method comprising:

illuminating a single measurement site of body tissue with optical radiation at a number of discrete wavelengths from a light source of said sensor, the number of discrete wavelengths consisting of one wavelength selected from a first wavelength band in a range of about 1620 nm to about 1655 nm when the light source emits said optical radiation at wavelengths in the first wavelength band, and consisting of one wavelength selected from a second wavelength band in a range of about 1000 nm to about 1102 nm when the light source emits said optical radiation at wavelengths in the second wavelength band;

detecting the optical radiation after attenuation by the body tissue, said detecting using an optical detector; and

outputting from said detector a signal indicative of the attenuation, the signal being usable by a patient monitor to determine one or more measurement values for blood glucose of the body tissue.

7. The method according to claim 6 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1650 nm±

5 nm when the light source emits said optical radiation at wavelengths in the first wavelength band.

8. The method according to claim 6 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1032 nm±

5 nm when the light source emits said optical radiation at wavelengths in the second wavelength band.

9. The method according to claim 6 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1097 nm±

5 nm when the light source emits said optical radiation at wavelengths in the second wavelength band.

10. The method according to claim 6 wherein the number of discrete wavelengths consists of one wavelength selected from a third wavelength band in a range of about 2000 nm to about 2500 nm when the light source emits said optical radiation at wavelengths in the third wavelength band.

11. A patient monitoring system, comprising:

means for illuminating a single measurement site of body tissue with optical radiation at a number of narrowbands, the number of narrowbands consisting of one narrowband selected from a first wavelength band in a range of about 1620 nm to about 1655 nm when emitting said optical radiation at narrowbands in the first wavelength band, and consisting of one narrowband selected from a second wavelength band in a range of about 1000 nm to about 1102 nm when emitting said optical radiation at narrowbands in the second wavelength band; and

means for detecting the optical radiation after attenuation by the body tissue and outputting a signal indicative of the attenuation, the signal being usable by a patient monitor to determine one or more measurement values for blood glucose of the body tissue.

12. The patient monitoring system according to claim 11 wherein the number of narrowbands consists of one narrowband from a range of about 1650 nm±

5 nm when emitting said optical radiation at narrowbands in the first wavelength band.

13. The patient monitoring system according to claim 11 wherein the number of narrowbands consists of one narrowband from a range of about 1032 nm±

5 nm when emitting said optical radiation at narrowbands in the second wavelength band.

14. The patient monitoring system according to claim 11 wherein the number of narrowbands consists of one narrowband from a range of about 1097 nm±

5 nm when emitting said optical radiation at narrowbands in the second wavelength band.

15. A noninvasive optical sensor capable of outputting a signal usable by a patient monitor to determine one or more physiological parameters of a wearer of the optical sensor, the optical sensor comprising:

a light source configured to irradiate tissue at a single tissue location, the light source emitting optical radiation at a number of discrete wavelengths, the number of discrete wavelengths consisting of one wavelength from a first wavelength band in a range of about 1620 nm to about 1655 nm when the light source emits said optical radiation at wavelengths in the first wavelength band, and consisting of one wavelength from a second wavelength band in a range of about 1375 nm±

5 nm when the light source emits said optical radiation at wavelengths in the second wavelength band, and

a detector capable of detecting the optical radiation after attenuation by body tissue and of outputting a signal indicative of the attenuation by the body tissue, the signal being usable by a patient monitor to determine one or more measurement values for blood glucose of the body tissue.

16. The noninvasive optical sensor according to claim 15 wherein the number of discrete wavelengths consists of one wavelength from a range of about 1650 nm±

5 nm when the light source emits said optical radiation at wavelengths in the first wavelength band.